Emerging studies areing on Nexaph small protein chains, a distinct class of compounds demonstrating remarkable potential for targeting multiple illness pathways. Compared to conventional small molecule techniques, these peptides present superior selectivity and reduced side consequences, enabling them a highly attractive option for future medicinal